Supporting Student Mental Health With the Safespace Generative AI Chatbot: Mixed Methods Feasibility Study
JMIR Formative Research · 2026
DOI: 10.2196/85427 ↗Kurz gefasst
Mixed-Methods-Studie in der Zeitschrift JMIR Formative Research, 2026. Verfasst von Matteo Pinna und 3 weiteren Autor:innen. Beteiligte Einrichtung: Center for Law and Economics, Department of Humanities, Social and Political Sciences, ETH Zürich, Haldeneggsteig 4, Zürich, 8092, Switzerland, +41 4…. Hauptthemen laut MEDLINE: Students, Mental Health. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Swiss National Science Foundation.
Abstract (Originalsprache)
Background
Generative artificial intelligence (GenAI) chatbots have the potential to provide personalized mental health support to individuals at scale.
Objective
This study evaluates the feasibility and usage patterns of the Safespace GenAI chatbot, an artificial intelligence (AI)–driven smartphone app that offers a large language model–powered interactive chatbot to support mental health.
Methods
Using a mixed methods approach, we explored baseline attitudes toward GenAI chatbots and chatbot usage patterns, conducted a qualitative content analysis of participants’ experiences, and descriptively assessed patterns related to preintervention depressive symptoms. The study included an initial sample of 42 university students, 20 of whom actively used the chatbot over 2 to 4 weeks, generating 286 user-chatbot interactions.
Results
Preintervention surveys indicated that the majority of participants anticipated that the chatbot would be helpful (27/42, 64%) and that they trusted its privacy safeguards (39/42, 93%). Usage patterns suggested that the highest levels of interaction occurred early in the morning and late at night, when peer and professional support may be inaccessible. The qualitative analysis indicated that participants appreciated using the chatbot for reflection as a blended-care tool between their counseling sessions, while also naming technical barriers and specific design needs required to sustain engagement. In addition, our exploratory analyses descriptively showed that participants with elevated depression scores engaged in emotional disclosure during 99% (38 sessions with 8 participants) of their sessions, compared to 84% (26 sessions of 12 participants) of those with low symptoms. Due to the small sample size, future adequately powered studies are needed to inferentially examine these observed patterns.
Conclusions
These findings provide initial insights into the usage and engagement dynamics of the Safespace GenAI chatbot and highlight directions for future research to optimize GenAI-driven mental health interventions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center for Law and Economics, Department of Humanities, Social and Political Sciences, ETH Zürich, Haldeneggsteig 4, Zürich, 8092, Switzerland, +41 44 6324586.
- Safespace Research AG, Zürich, Switzerland.
- Department of Economics and Law, Sapienza University of Rome, Rome, Italy.
- Applied Social and Health Psychology, Department of Psychology, University of Zürich, Zürich, Switzerland.
ORCID-Profile: Matteo Pinna, Sergio Galletta, Elliott Ash, Timon Elmer
Förderung
- Swiss National Science Foundation
Zitieren
APA
Pinna, M., Galletta, S., Ash, E., & Elmer, T. (2026). Supporting Student Mental Health With the Safespace Generative AI Chatbot: Mixed Methods Feasibility Study. JMIR Formative Research. https://doi.org/10.2196/85427
Vancouver
Pinna M, Galletta S, Ash E, Elmer T. Supporting Student Mental Health With the Safespace Generative AI Chatbot: Mixed Methods Feasibility Study. JMIR Formative Research. 2026. doi:10.2196/85427
BibTeX
@article{Pinna2026,
author = {Pinna, Matteo and Galletta, Sergio and Ash, Elliott and Elmer, Timon},
title = {Supporting Student Mental Health With the Safespace Generative AI Chatbot: Mixed Methods Feasibility Study},
journal = {JMIR Formative Research},
year = {2026},
doi = {10.2196/85427}
}
EUVIMED